glycyl-arginyl-glycyl-aspartyl-seryl-proline and Acute Disease

glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Acute Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aoki, K; Fuchigami, A; Hayashi, A; Huang, YH; Ishiko, H; Kadonosono, K; Kimura, R; Ohno, S; Uchio, E	1

Other Studies

1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Acute Disease

Article	Year
Antiadenoviral effect of the alpha 5 beta 1 integrin receptor ligand, GRGDSP peptide, in serotypes that cause acute keratoconjunctivitis. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2007, Volume: 221, Issue:5 Topics: Acute Disease; Adenoviridae; Adenoviridae Infections; Antiviral Agents; Cell Line; Dose-Response Relationship, Drug; Humans; Integrin alpha5beta1; Keratoconjunctivitis; Ligands; Oligopeptides; Serotyping; Virus Replication	2007

Article

Year

Antiadenoviral effect of the alpha 5 beta 1 integrin receptor ligand, GRGDSP peptide, in serotypes that cause acute keratoconjunctivitis.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2007, Volume: 221, Issue:5

Topics: Acute Disease; Adenoviridae; Adenoviridae Infections; Antiviral Agents; Cell Line; Dose-Response Relationship, Drug; Humans; Integrin alpha5beta1; Keratoconjunctivitis; Ligands; Oligopeptides; Serotyping; Virus Replication

2007